# EDGAR Filing Document

**Accession Number:** 0001773195
**File Stem:** 0001387131-23-001890
**Filing Date:** 2023-2
**Character Count:** 10235
**Document Hash:** 24c66d0202c20abb122ff9e4aac16ad9
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001387131-23-001890.hdr.sgml**: 20230213

**ACCESSION NUMBER**: 0001387131-23-001890

**CONFORMED SUBMISSION TYPE**: 13F-HR

**PUBLIC DOCUMENT COUNT**: 2

**CONFORMED PERIOD OF REPORT**: 20221231

**FILED AS OF DATE**: 20230213

**DATE AS OF CHANGE**: 20230213

**EFFECTIVENESS DATE**: 20230213

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** Affinity Asset Advisors, LLC
- **CENTRAL INDEX KEY:** 0001773195
- **IRS NUMBER:** 821567490
- **STATE OF INCORPORATION:** DE
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** 13F-HR
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 028-20754
- **FILM NUMBER:** 23618274

**BUSINESS ADDRESS:**
- **STREET 1:** 767 THIRD AVENUE
- **STREET 2:** 15TH FLOOR
- **CITY:** NEW YORK
- **STATE:** NY
- **ZIP:** 10017
- **BUSINESS PHONE:** 917-826-4533

**MAIL ADDRESS:**
- **STREET 1:** 767 THIRD AVENUE
- **STREET 2:** 15TH FLOOR
- **CITY:** NEW YORK
- **STATE:** NY
- **ZIP:** 10017

### FORM 13F COVER PAGE

**Report for the Calendar Year or Quarter Ended:** 12-31-2022

**Check here if Amendment** [ ] **Amendment Number:** 

**This Amendment (Check only one.):** [ ] is a restatement.

[ ] adds new holdings entries.

**Institutional Investment Manager Filing this Report:**

**Name:** Affinity Asset Advisors LLC<br>**Address:** 767 Third Avenue<br>15th Floor<br>New York, NY 10017

**Form 13F File Number:** 028-20754

**CRD Number (if applicable):** 000312788

**SEC File Number (if applicable):** 801-120744

The institutional investment manager filing this report and the person by whom it is signed hereby represent that the person signing the report is authorized to submit it, that all information contained herein is true, correct and complete, and that it is understood that all required items, statements, schedules, lists, and tables, are considered integral parts of this form.

**Person Signing this Report on Behalf of Reporting Manager:**

**Name:** Jonathan Chu<br>**Title:** Chief Compliance Officer<br>**Phone:** 646-481-8008

**Signature, Place, and Date of Signing:**

/s/ Jonathan Chu  New York, NY  02-13-2023<br>[Signature]  [City, State]  [Date]

**Report Type (Check only one.):**

[x] **13F HOLDINGS REPORT.** (Check here if all holdings of this reporting manager are reported in this report.)

[ ] **13F NOTICE.** (Check here if no holdings are reported in this report, and all holdings are reported by other reporting manager(s).)

[ ] **13F COMBINATION REPORT.** (Check here if a portion of the holdings for this reporting manager are reported in this report and a portion are reported by other reporting manager(s).)

### Form 13F Summary Page

**Report Summary:**

**Number of Other Included Managers:** 0

**Form 13F Information Table Entry Total:** 63

**Form 13F Information Table Value Total:** $254989593

      (round to nearest dollar)

**List of Other Included Managers:**

Provide a numbered list of the name(s) and Form 13F file number(s) of all institutional investment managers with respect to which this report is filed, other than the manager filing this report.

[If there are no entries in this list, state “NONE” and omit the column headings and list entries.]

**NONE**

### FORM 13F INFORMATION TABLE

---

|  |  |  |  |  |  |  |  |  |  |  |  |  |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| NAME OF ISSUER | TITLE OF CLASS | CUSIP | FIGI | VALUE (x$1000) | SHRS OR PRN AMT | SH/PRN | PUT/CALL | INVESTMENT DISCRETION | OTHER MANAGER | VOTING AUTHORITY | VOTING AUTHORITY | VOTING AUTHORITY |
| NAME OF ISSUER | TITLE OF CLASS | CUSIP | FIGI | VALUE (x$1000) | SHRS OR PRN AMT | SH/PRN | PUT/CALL | INVESTMENT DISCRETION | OTHER MANAGER | SOLE | SHARED | NONE |
| ALPINE IMMUNE SCIENCES INC | COM | 02083G100 |  | 1821999 | 247891 | SH |  | SOLE |  | 247891 | 0 | 0 |
| AMGEN INC | COM | 031162100 |  | 5252800 | 20000 | SH | Put | SOLE |  | 20000 | 0 | 0 |
| ARCELLX INC | COMMON STOCK | 03940C100 |  | 7439630 | 240143 | SH |  | SOLE |  | 240143 | 0 | 0 |
| ARGENX SE | SPONSORED ADR | 04016X101 |  | 1894150 | 5000 | SH |  | SOLE |  | 5000 | 0 | 0 |
| ASCENDIS PHARMA A S | SPONSORED ADR | 04351P101 |  | 8670864 | 70997 | SH |  | SOLE |  | 70997 | 0 | 0 |
| ASTRAZENECA PLC | SPONSORED ADR | 046353108 |  | 4068000 | 60000 | SH |  | SOLE |  | 60000 | 0 | 0 |
| ASTRIA THERAPEUTICS INC | COM | 04635X102 |  | 7035257 | 472482 | SH |  | SOLE |  | 472482 | 0 | 0 |
| BELLUS HEALTH INC NEW | COM NEW | 07987C204 |  | 4715633 | 573678 | SH |  | SOLE |  | 573678 | 0 | 0 |
| BIOATLA INC | COM | 09077B104 |  | 1237500 | 150000 | SH |  | SOLE |  | 150000 | 0 | 0 |
| BIOMARIN PHARMACEUTICAL INC | COM | 09061G101 |  | 8279200 | 80000 | SH |  | SOLE |  | 80000 | 0 | 0 |
| BRIDGEBIO PHARMA INC | NOTE 2.250% 2/0 | 10806XAD4 |  | 3895290 | 10000000 | PRN |  | SOLE |  | 10000000 | 0 | 0 |
| BRIDGEBIO PHARMA INC | NOTE 2.500% 3/1 | 10806XAB8 |  | 3410048 | 7500000 | PRN |  | SOLE |  | 7500000 | 0 | 0 |
| BRISTOL MYERS SQUIBB CO | COM | 110122108 |  | 12591250 | 175000 | SH | Put | SOLE |  | 175000 | 0 | 0 |
| CELLDEX THERAPEUTICS INC NEW | COM NEW | 15117B202 |  | 4902700 | 110000 | SH |  | SOLE |  | 110000 | 0 | 0 |
| CENTESSA PHARMACEUTICALS PLC | SPONSORED ADS | 152309100 |  | 1427017 | 460328 | SH |  | SOLE |  | 460328 | 0 | 0 |
| CEREVEL THERAPEUTICS HLDNG I | COM | 15678U128 |  | 6781100 | 215000 | SH |  | SOLE |  | 215000 | 0 | 0 |
| CHINOOK THERAPEUTICS INC | COM | 16961L106 |  | 21432517 | 818035 | SH |  | SOLE |  | 818035 | 0 | 0 |
| COGENT BIOSCIENCES INC | COM | 19240Q201 |  | 2231820 | 193064 | SH |  | SOLE |  | 193064 | 0 | 0 |
| CONTEXT THERAPEUTICS INC | COM | 21077P108 |  | 583653 | 883654 | SH |  | SOLE |  | 883654 | 0 | 0 |
| CYMABAY THERAPEUTICS INC | COM | 23257D103 |  | 7169939 | 1143531 | SH |  | SOLE |  | 1143531 | 0 | 0 |
| CYTOKINETICS INC | COM NEW | 23282W605 |  | 4013878 | 87601 | SH |  | SOLE |  | 87601 | 0 | 0 |
| DYNE THERAPEUTICS INC | COM | 26818M108 |  | 1068250 | 92170 | SH |  | SOLE |  | 92170 | 0 | 0 |
| ESPERION THERAPEUTICS INC NE | NOTE 4.000%11/1 | 29664WAB1 |  | 1363928 | 2500000 | PRN |  | SOLE |  | 2500000 | 0 | 0 |
| ESTABLISHMENT LABS HLDGS INC | COM | G31249108 |  | 12523854 | 190767 | SH |  | SOLE |  | 190767 | 0 | 0 |
| FOGHORN THERAPEUTICS INC | COM | 344174107 |  | 701743 | 109991 | SH |  | SOLE |  | 109991 | 0 | 0 |
| GERON CORP | COM | 374163103 |  | 2556730 | 1056500 | SH | Put | SOLE |  | 1056500 | 0 | 0 |
| GERON CORP | COM | 374163103 |  | 2025540 | 837000 | SH | Call | SOLE |  | 837000 | 0 | 0 |
| HORIZON THERAPEUTICS PUB L | SHS | G46188101 |  | 5121000 | 45000 | SH |  | SOLE |  | 45000 | 0 | 0 |
| IMMATICS N.V | *W EXP 07/01/202 | N44445117 |  | 469882 | 187204 | SH |  | SOLE |  | 187204 | 0 | 0 |
| INARI MED INC | COM | 45332Y109 |  | 5720400 | 90000 | SH |  | SOLE |  | 90000 | 0 | 0 |
| INOZYME PHARMA INC | COM | 45790W108 |  | 525000 | 500000 | SH |  | SOLE |  | 500000 | 0 | 0 |
| IOVANCE BIOTHERAPEUTICS INC | COM | 462260100 |  | 2396250 | 375000 | SH |  | SOLE |  | 375000 | 0 | 0 |
| KALVISTA PHARMACEUTICALS INC | COM | 483497103 |  | 1272854 | 188292 | SH |  | SOLE |  | 188292 | 0 | 0 |
| KARYOPHARM THERAPEUTICS INC | COM | 48576U106 |  | 2248298 | 661264 | SH |  | SOLE |  | 661264 | 0 | 0 |
| KURA ONCOLOGY INC | COM | 50127T109 |  | 3335150 | 268747 | SH |  | SOLE |  | 268747 | 0 | 0 |
| LANTHEUS HLDGS INC | COM | 516544103 |  | 3089705 | 60630 | SH |  | SOLE |  | 60630 | 0 | 0 |
| LIANBIO | SPONSORED ADS | 53000N108 |  | 1066000 | 650000 | SH |  | SOLE |  | 650000 | 0 | 0 |
| MADRIGAL PHARMACEUTICALS INC | COM | 558868105 |  | 20317500 | 70000 | SH |  | SOLE |  | 70000 | 0 | 0 |
| MEDICUS SCIENCES ACQUISITION | *W EXP 02/12/202 | G5960S124 |  | 2933 | 33333 | SH |  | SOLE |  | 33333 | 0 | 0 |
| MILESTONE PHARMACEUTICALS IN | COM | 59935V107 |  | 396000 | 100000 | SH |  | SOLE |  | 100000 | 0 | 0 |
| MIRUM PHARMACEUTICALS INC | COM | 604749101 |  | 780000 | 40000 | SH |  | SOLE |  | 40000 | 0 | 0 |
| MODERNA INC | COM | 60770K107 |  | 5388600 | 30000 | SH | Put | SOLE |  | 30000 | 0 | 0 |
| MORPHIC HLDG INC | COM | 61775R105 |  | 7514637 | 280921 | SH |  | SOLE |  | 280921 | 0 | 0 |
| NOVAVAX INC | COM NEW | 670002401 |  | 2056000 | 200000 | SH | Put | SOLE |  | 200000 | 0 | 0 |
| NOVOCURE LTD | ORD SHS | G6674U108 |  | 1833750 | 25000 | SH | Call | SOLE |  | 25000 | 0 | 0 |
| NURIX THERAPEUTICS INC | COM | 67080M103 |  | 878400 | 80000 | SH |  | SOLE |  | 80000 | 0 | 0 |
| NUVATION BIO INC | COM CL A | 67080N101 |  | 480000 | 250000 | SH |  | SOLE |  | 250000 | 0 | 0 |
| POINT BIOPHARMA GLOBAL INC | COM | 730541109 |  | 2210459 | 303218 | SH |  | SOLE |  | 303218 | 0 | 0 |
| PRECIGEN INC | NOTE 3.500% 7/0 | 46122TAA0 |  | 1487981 | 1500000 | PRN |  | SOLE |  | 1500000 | 0 | 0 |
| PROMETHEUS BIOSCIENCES INC | COM | 74349U108 |  | 8250000 | 75000 | SH |  | SOLE |  | 75000 | 0 | 0 |
| ROCKET PHARMACEUTICALS INC | COM | 77313F106 |  | 5051311 | 258115 | SH |  | SOLE |  | 258115 | 0 | 0 |
| SCILEX HOLDING CO | *W EXP 11/10/202 | 80880W114 |  | 3419 | 18099 | SH |  | SOLE |  | 18099 | 0 | 0 |
| SCILEX HOLDING CO | COM | 80880W106 |  | 1847 | 463 | SH |  | SOLE |  | 463 | 0 | 0 |
| SEAGEN INC | COM | 81181C104 |  | 642550 | 5000 | SH |  | SOLE |  | 5000 | 0 | 0 |
| SYNDAX PHARMACEUTICALS INC | COM | 87164F105 |  | 2545000 | 100000 | SH |  | SOLE |  | 100000 | 0 | 0 |
| VAXCYTE INC | COM | 92243G108 |  | 2877000 | 60000 | SH |  | SOLE |  | 60000 | 0 | 0 |
| VENTYX BIOSCIENCES INC | COM | 92332V107 |  | 7890028 | 240623 | SH |  | SOLE |  | 240623 | 0 | 0 |
| VERONA PHARMA PLC | SPONSORED ADR | 925050106 |  | 8165573 | 312498 | SH |  | SOLE |  | 312498 | 0 | 0 |
| VERONA PHARMA PLC | SPONSORED ADS | 925050106 |  | 2743650 | 105000 | SH | Call | SOLE |  | 105000 | 0 | 0 |
| VIKING THERAPEUTICS INC | COM | 92686J106 |  | 3290000 | 350000 | SH |  | SOLE |  | 350000 | 0 | 0 |
| VIKING THERAPEUTICS INC | COM | 92686J106 |  | 2350000 | 250000 | SH | Call | SOLE |  | 250000 | 0 | 0 |
| VINCERX PHARMA INC | COM NEW | 92731L106 |  | 1522626 | 1492771 | SH |  | SOLE |  | 1492771 | 0 | 0 |
| XENON PHARMACEUTICALS INC | COM | 98420N105 |  | 1971500 | 50000 | SH |  | SOLE |  | 50000 | 0 | 0 |

---